20
Participants
Start Date
September 3, 2024
Primary Completion Date
August 29, 2025
Study Completion Date
September 16, 2025
PrabotulinumtoxinA-Xvfs
Each vial of prabotulinumtoxinA-xvfs contains 100 units of product, and it will be reconstituted with 5 mL of bacteriostatic saline solution. 20 units of this intervention will only be injected to the left side of subject faces - intramuscularly to the corrugator supercilii and intradermally to the forehead region.
IncobotulinumtoxinA
Each vial of incobotulinumtoxinA contains 100 units of product, and it will be reconstituted with 5 mL of bacteriostatic saline solution. 20 units of this intervention will only be injected to the right side of subject faces - intramuscularly to the corrugator supercilii and intradermally to the forehead region.
saline solution (placebo)
As a placebo treatment, saline solution will be injected on the right side of the glabellar lines and forehead region instead of an active neuromodulator. The saline solution has no therapeutic effect and is used as a control to compare the results against the active treatment.
K. Kay Durairaj, MD, A Medical Corp., Pasadena
Collaborators (1)
Evolus, Inc.
INDUSTRY
Kalpna Kay Durairaj, MD, FACS
OTHER